Stephen S. Dominy - Jan 3, 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Chief Scientific Officer, Director
Signature
/s/ Caryn Gordon McDowell, as Attorney-in-Fact for Stephen S. Dominy
Stock symbol
QNCX
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:53 PM
Previous filing
Nov 12, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +125K $0.00 125K Jan 3, 2022 Common Stock 125K $13.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the date of grant, such that the total number of shares shall be fully vested on the four-year anniversary of the date of grant.